-transparent.png){kind=logo}
One to four different lots of four commercially available trivalent measles-mumps-rubella vaccines were tested for their efficacy as measured by the induction of antibodies to the three vaccine viruses. All of the products were satisfactory although a 100% seroconversion rate was attained regularly only with rubella vaccine. The live virus in the different measles and mumps vaccine components and especially the relative amounts of measles to mumps virus varied widely. Obviously, the efficacy of a vaccine should not be judged only by the virus content. Of main importance is the further adjustment of the dosage of the interfering vaccine virus strains in relation to their attenuation.
R Berger, and
M Just, and
R Glück
January 1970,
Bulletin of the World Health Organization,
R Berger, and
M Just, and
R Glück
March 1969,
JAMA,
R Berger, and
M Just, and
R Glück
January 1972,
Revista de investigacion en salud publica,
R Berger, and
M Just, and
R Glück
May 1971,
American journal of diseases of children (1960),
R Berger, and
M Just, and
R Glück
July 1973,
Archives of disease in childhood,
R Berger, and
M Just, and
R Glück
March 1973,
Pediatrics,
R Berger, and
M Just, and
R Glück
February 1999,
Vaccine,
R Berger, and
M Just, and
R Glück
June 1973,
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
R Berger, and
M Just, and
R Glück
May 1975,
Monatsschrift fur Kinderheilkunde,
R Berger, and
M Just, and
R Glück
February 1992,
Kinderarztliche Praxis,
